Zenas BioPharma, Inc. (ZBIO), Monday announced the appointment of Lisa von Moltke as the company's Head of Research and Development and Chief Medical Officer.
Most recently, von Moltke served as CMO at Seres Therapeutics with functional oversight of clinical development, sciences and operations, and regulatory and medical affairs.
Friday, Zenas's stock closed at $8.25, down 5.50 percent on the Nasdaq.
For comments and feedback: editorial@rttnews.com